<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-MedLine.d57">
    <sentence id="DDI-MedLine.d57.s0" text="Analgesic effects of antihistaminics.&#xa;">
        <entity id="DDI-MedLine.d57.s0.e0" charOffset="21-35"
            type="group" text="antihistaminics"/>
    </sentence>
    <sentence id="DDI-MedLine.d57.s1" text="The literature provides considerable evidence indicating that several, but not all antihistaminics, are indeed analgesic agents and some are analgesic adjuvants as well.">
        <entity id="DDI-MedLine.d57.s1.e0" charOffset="83-97"
            type="group" text="antihistaminics"/>
        <entity id="DDI-MedLine.d57.s1.e1" charOffset="111-126"
            type="group" text="analgesic agents"/>
        <entity id="DDI-MedLine.d57.s1.e2" charOffset="141-159"
            type="group" text="analgesic adjuvants"/>
    </sentence>
    <sentence id="DDI-MedLine.d57.s2" text="Those for which effectiveness is reported includes diphenhydramine, hydroxyzine, orphenadrine, pyrilamine, phenyltoloxamine, promethazine, methdilazine, and tripelennamine. ">
        <entity id="DDI-MedLine.d57.s2.e0" charOffset="51-65"
            type="drug" text="diphenhydramine"/>
        <entity id="DDI-MedLine.d57.s2.e1" charOffset="68-78"
            type="drug" text="hydroxyzine"/>
        <entity id="DDI-MedLine.d57.s2.e2" charOffset="81-92"
            type="drug" text="orphenadrine"/>
        <entity id="DDI-MedLine.d57.s2.e3" charOffset="95-104"
            type="drug" text="pyrilamine"/>
        <entity id="DDI-MedLine.d57.s2.e4" charOffset="107-122"
            type="drug_n" text="phenyltoloxamine"/>
        <entity id="DDI-MedLine.d57.s2.e5" charOffset="125-136"
            type="drug" text="promethazine"/>
        <entity id="DDI-MedLine.d57.s2.e6" charOffset="139-150"
            type="drug" text="methdilazine"/>
        <entity id="DDI-MedLine.d57.s2.e7" charOffset="157-170"
            type="drug" text="tripelennamine"/>
    </sentence>
    <sentence id="DDI-MedLine.d57.s3" text="The proposed mechanisms of analgesic action of antihistaminics are reviewed and discussed. ">
        <entity id="DDI-MedLine.d57.s3.e0" charOffset="47-61"
            type="group" text="antihistaminics"/>
    </sentence>
    <sentence id="DDI-MedLine.d57.s4" text="The literature suggests that more than one mechanism of action exists for them. "/>
    <sentence id="DDI-MedLine.d57.s5" text="There is considerable evidence suggesting that histaminergic and serotoninergic central pathways are involved in nociception and that antihistaminic drugs can modulate their responses (1). ">
        <entity id="DDI-MedLine.d57.s5.e0" charOffset="134-147"
            type="group" text="antihistaminic"/>
    </sentence>
    <sentence id="DDI-MedLine.d57.s6" text="The evidence for a role for norepinephrine and dopamine and the effects of antihistaminics on them are less well established. ">
        <entity id="DDI-MedLine.d57.s6.e0" charOffset="75-89"
            type="group" text="antihistaminics"/>
    </sentence>
    <sentence id="DDI-MedLine.d57.s7" text="Still other pathways have been proposed. "/>
    <sentence id="DDI-MedLine.d57.s8" text="A greater understanding of pain mechanisms will aid in elucidating the role of antihistaminics in analgesia.">
        <entity id="DDI-MedLine.d57.s8.e0" charOffset="79-93"
            type="group" text="antihistaminics"/>
    </sentence>
</document>
